WASHINGTON, Jan. 17, 2019 /PRNewswire/ -- The Antimicrobials
Working Group (AWG) announced today the appointment of a new
Chairman, Evan Loh, M.D., President,
Chief Operating Officer and Chief Medical Officer of Paratek
Pharmaceuticals, Inc. Dr. Loh replaces Jeffrey Stein, Ph.D., President and Chief
Executive Officer of Cidara Therapeutics, whose two-year term as
Chairman of AWG has expired. Dr. Stein will remain on the AWG
Executive Committee. The AWG also announced that Ciara Kennedy, Ph.D., President and Chief
Executive Officer of Amplyx Pharmaceuticals, Inc. has been
appointed as Vice Chair, joining Vice Chair Michael Dunne, M.D., Chief Scientific Officer of
Iterum Therapeutics. Additionally, Ted
Schroeder, Chief Executive Officer of Nabriva Therapeutics
has joined the AWG Executive Committee.
"On behalf of the AWG I would like to thank Jeff for his
leadership over the past two years," said Dr. Evan Loh,
incoming chairman. "Jeff has been an integral part of AWG since the
coalition's inception in 2012 and has worked tirelessly to advance
AWG's mission of improving the regulatory, investment, and
commercial environment for antimicrobial drug and diagnostic device
development companies. I look forward to working with the AWG
Executive Committee and Board as we push to drive legislation and
public policy that will encourage reinvestment in the development
of new antimicrobials during this critical time in the fight
against drug resistant pathogens."
About The Antimicrobials Working Group
AWG was founded
in 2012 with the vision of utilizing collective power to improve
the regulatory, investment, and commercial environment for emerging
infectious disease companies. Today, AWG is comprised of fourteen
antimicrobials companies: Amplyx Pharmaceuticals, Aridis
Pharmaceuticals, Cidara Therapeutics Inc. (NASDAQ: CDTX),
ContraFect Corporation (NASDAQ: CFRX), Entasis Therapeutics Inc.,
Iterum Therapeutics Ltd. (NASDAQ: ITRM), Melinta Therapeutics Inc.
(NASDAQ: MLNT), Motif Bio PLC (AIM/NASDAQ: MTFB) , Nabriva
Therapeutics US Inc. (NASDAQ: NBRV), Paratek Pharmaceuticals Inc.
(NASDAQ: PRTK), Qpex Biopharma, Inc., SCYNEXIS Inc. (NASDAQ: SCYX),
Summit Therapeutics plc (NASDAQ: SMMT) (AIM: SUMM), and VenatoRx
Pharmaceuticals, Inc.
For more information, visit:
www.antimicrobialsworkinggroup.org
About The Conafay Group
The Conafay Group, led by
Stephen R. Conafay, Principal, is a
life-sciences government relations firm based in Washington D.C. that serves as Washington counsel and coalition manager for
AWG.
For more information, visit: www.conafaygroup.com
View original
content:http://www.prnewswire.com/news-releases/antimicrobials-working-group-announces-updates-to-leadership-team-300779009.html
SOURCE Antimicrobials Working Group (AWG)